Literature DB >> 25431839

Role of the blood-brain barrier in multiple sclerosis.

Genaro Gabriel Ortiz1, Fermín Paul Pacheco-Moisés2, Miguel Ángel Macías-Islas3, Luis Javier Flores-Alvarado4, Mario A Mireles-Ramírez3, Erika Daniela González-Renovato5, Vanessa Elizabeth Hernández-Navarro5, Angélica Lizeth Sánchez-López5, Moisés Alejandro Alatorre-Jiménez5.   

Abstract

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system associated with demyelination and axonal loss eventually leading to neurodegeneration. MS exhibits many of the hallmarks of an inflammatory autoimmune disorder including breakdown of the blood-brain barrier (BBB). The BBB is a complex organization of cerebral endothelial cells, pericytes and their basal lamina, which are surrounded and supported by astrocytes and perivascular macrophages. In pathological conditions, lymphocytes activated in the periphery infiltrate the central nervous system to trigger a local immune response that ultimately damages myelin and axons. Cytotoxic factors including pro-inflammatory cytokines, proteases, and reactive oxygen and nitrogen species accumulate and may contribute to myelin destruction. Dysregulation of the BBB and transendothelial migration of activated leukocytes are among the earliest cerebrovascular abnormalities seen in MS brains and parallel the release of inflammatory cytokines. In this review we establish the importance of the role of the BBB in MS. Improvements in our understanding of molecular mechanism of BBB functioning in physiological and pathological conditions could lead to improvement in the quality of life of MS patients.
Copyright © 2015 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood–brain barrier; Central nervous system; Multiple sclerosis; Oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 25431839     DOI: 10.1016/j.arcmed.2014.11.013

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  83 in total

1.  Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients.

Authors:  Kelly Fellows; Tomas Uher; Richard W Browne; Bianca Weinstock-Guttman; Dana Horakova; Helena Posova; Manuela Vaneckova; Zdenek Seidl; Jan Krasensky; Michaela Tyblova; Eva Havrdova; Robert Zivadinov; Murali Ramanathan
Journal:  J Lipid Res       Date:  2015-08-04       Impact factor: 5.922

2.  Impact of cervical stenosis on multiple sclerosis lesion distribution in the spinal cord.

Authors:  Daniel Gratch; David Do; Pouya Khankhanian; Matthew Schindler; J Eric Schmitt; Joseph R Berger
Journal:  Mult Scler Relat Disord       Date:  2020-07-20       Impact factor: 4.339

3.  Longitudinal Persistence of Meningeal Enhancement on Postcontrast 7T 3D-FLAIR MRI in Multiple Sclerosis.

Authors:  S N Jonas; I Izbudak; A A Frazier; D M Harrison
Journal:  AJNR Am J Neuroradiol       Date:  2018-09-13       Impact factor: 3.825

4.  Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.

Authors:  Min Jung Lee; Minhee Jang; Jonghee Choi; Byung Soo Chang; Do Young Kim; Sung-Hoon Kim; Yi-Seong Kwak; Seikwan Oh; Jong-Hwan Lee; Byung-Joon Chang; Seung-Yeol Nah; Ik-Hyun Cho
Journal:  Mol Neurobiol       Date:  2015-04-07       Impact factor: 5.590

Review 5.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

6.  Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM.

Authors:  Kofi Deh; Gerald D Ponath; Zaki Molvi; Gian-Carlo T Parel; Kelly M Gillen; Shun Zhang; Thanh D Nguyen; Pascal Spincemaille; Yinghua Ma; Ajay Gupta; Susan A Gauthier; David Pitt; Yi Wang
Journal:  J Magn Reson Imaging       Date:  2018-03-08       Impact factor: 4.813

Review 7.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

Review 8.  Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.

Authors:  Mahshid Yeganeh Salehpour; Adriano Mollica; Saeideh Momtaz; Nima Sanadgol; Mohammad Hosein Farzaei
Journal:  Clin Drug Investig       Date:  2019-07       Impact factor: 2.859

9.  ZO-1 expression is suppressed by GM-CSF via miR-96/ERG in brain microvascular endothelial cells.

Authors:  Hu Zhang; Shuhong Zhang; Jilin Zhang; Dongxin Liu; Jiayi Wei; Wengang Fang; Weidong Zhao; Yuhua Chen; Deshu Shang
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-21       Impact factor: 6.200

10.  Identification of tissue-specific cell death using methylation patterns of circulating DNA.

Authors:  Roni Lehmann-Werman; Daniel Neiman; Hai Zemmour; Joshua Moss; Judith Magenheim; Adi Vaknin-Dembinsky; Sten Rubertsson; Bengt Nellgård; Kaj Blennow; Henrik Zetterberg; Kirsty Spalding; Michael J Haller; Clive H Wasserfall; Desmond A Schatz; Carla J Greenbaum; Craig Dorrell; Markus Grompe; Aviad Zick; Ayala Hubert; Myriam Maoz; Volker Fendrich; Detlef K Bartsch; Talia Golan; Shmuel A Ben Sasson; Gideon Zamir; Aharon Razin; Howard Cedar; A M James Shapiro; Benjamin Glaser; Ruth Shemer; Yuval Dor
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.